Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients

British Journal of Dermatology

Volumn 150, Issue 3, 2004, Pages 477-483

  Blaheta, H J ^a   Roeger, S ^a   Sotlar, K ^a   Schittek, B ^a   Breuninger, H ^a   Bueltmann, B ^a   Garbe, C ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

MelanA; Melanoma; Reverse transcription polymerase chain reaction; Sentinel lymph node; Tyrosinase

Indexed keywords

MELAN A; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; SKIN TUMOR; TISSUE SLICE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 1842506689     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2004.05792.x     Document Type: Article

References (19)

1. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
2. Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-34.
3. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
4. Krag DN, Meijer SJ, Weaver DL et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654-8.
5. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-83.
6. Reintgen D, Cruse CW, Wells K et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-67.
7. Smith B, Selby P, Southgate J et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-9.
8. Blaheta H-J, Schittek B, Breuninger H et al. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer 1998; 79: 318-23.
9. Hatta N, Fujimoto A, Takehara K, Takata M. Mapping of occult melanoma micrometastases in the inguinal lymph node basin by Immunohistochemistry and RT-PCR. Melanoma Res 1999; 9: 401-6.
10. Bostick PJ, Morton DL, Turner RR et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999; 17: 3238-44.
11. Shivers SC, Wang XN, Li WG et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998; 280: 1410-15.
12. Blaheta H-J, Ellwanger U, Schittek B et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000; 114: 637-42.
13. Blaheta H-J, Paul T, Sotlar K et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol 2001; 145: 195-202.
14. Blaheta H-J, Schittek B, Breuninger H et al. Detection of melanoma micrometastasis in sentinel nodes by RT-PCR correlates with tumor thickness and is predictive for micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999; 23: 822-8.
15. Palmieri G, Ascierto PA, Cossu A et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001; 19: 1437-43.
16. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999; 23: 263-7.
17. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 1988; 12: 612-18.
18. Yu LL, Flotte TJ, Tanabe KK et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999; 86: 617-27.
19. Cochran AJ, Balda BR, Starz H et al. The Augsburg consensus - techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89: 236-41.